Rockefeller Capital Management’s Sonoma Pharmaceuticals SNOA Stock Holding History

Rockefeller Capital Management’s Portfolio SNOA Stock Details SNOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-646	Closed	-$2.51K	–	4829
2025 Q3	$2.51K	Buy	+646	New	+$2.54K	﹤0.01%	4046
2023 Q1	–	Sell	-4	Closed	–	–	3628
2022 Q4	$0	Hold	4	–	–	﹤0.01%	4181
2022 Q3	$0	Hold	4	–	–	﹤0.01%	4336
2022 Q2	$0	Hold	4	–	–	﹤0.01%	4371
2022 Q1	$0	Hold	4	–	–	﹤0.01%	4050
2021 Q4	$0	Hold	4	–	–	﹤0.01%	3981
2021 Q3	$0	Hold	4	–	–	﹤0.01%	3837
2021 Q2	$0	Hold	4	–	–	﹤0.01%	3590
2021 Q1	$0	Hold	4	–	–	﹤0.01%	3379
2020 Q4	$0	Hold	4	–	–	﹤0.01%	2996
2020 Q3	$0	Buy	+4	New	+$615	﹤0.01%	2775

Other funds holding SNOA

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MCWS

McKinley Carter Wealth Services Wheeling, West Virginia $1.94B AUM 20.7% 1-Year Est. Return

GRP

Global Retirement Partners San Rafael, California $6.54B AUM

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return

Rockefeller Capital Management's SNOA Position: Q4 2025 in Review

Rockefeller Capital Management sold out of Sonoma Pharmaceuticals (SNOA) in Q4 2025, closing a stake of 646 shares — an estimated $2.51K sold.

Rockefeller Capital Management first reported a position in SNOA in Q3 2020 and held it in 11 quarters. The position peaked at $2.51K in Q3 2025. 16 funds tracked by Wall St. Rank hold SNOA as of Q4 2025.

Rockefeller Capital Management reported no remaining Sonoma Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Rockefeller Capital Management sold 646 Sonoma Pharmaceuticals shares in Q4 2025, an estimated $2.51K.
Rockefeller Capital Management first reported a position in Sonoma Pharmaceuticals in Q3 2020 and held it in 11 quarters.
Rockefeller Capital Management's Sonoma Pharmaceuticals position peaked at $2.51K in Q3 2025.
16 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q4 2025.

Based on Rockefeller Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.